You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泛生子宣佈簽署私有化協議
格隆匯 10-12 07:29

10月12日,泛生子(NASDAQ:GTH)發佈公吿,宣佈已正式簽署私有化合並協議,對應泛生子交易估值約為1.26億美元。

根據協議,泛生子將與母公司(New Genetron Holding Limited)合併,泛生子將繼續作為存續實體,併成為母公司的全資子公司。參與此次交易的買方團包括中金康瑞醫療基金、Wealth Strategy Holding Limited、無錫國聯集團、建信(北京)投資基金管理有限責任公司、無錫惠宏贏康投資合夥企業(有限合夥)等。

協議顯示,每股普通股收購價格為0.272美元,每股美國存托股票(“ADS”,每股ADS代表5股普通股)收購價格為1.36美元。根據此次簽署的協議,此項交易的價格比泛生子宣佈收到私有化要約前的最後一個交易日,溢價約為15%;與宣佈收到私有化要約的前30個交易日平均收盤價相比,該報價溢價21%。截至2023年10月11日,即公吿發布前最後一個交易日,溢價42%。

公吿稱,私有化交易預計於2024年一季度完成。

公開資料顯示,泛生子是全球前沿的癌症精準醫療公司,提供癌症早期篩查、診斷與監測、藥物研發服務等覆蓋癌症全週期的產品與服務,全面覆蓋中國十大癌種,並擁有“一步法”、Mutation Capsule等原研專利技術。此外,泛生子是唯一一家進入科技部肝癌、肺癌、消化道癌等多癌種早篩國家重大專項的精準醫療企業,其肺癌精準診療項目榮獲國家科技進步二等獎。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account